Clinical Trials Arena August 23, 2024
GlobalData Healthcare

The most frequently utilised guideline for diagnosis was the American Academy of Pediatrics’ Clinical Practice Guideline.

Attention deficit hyperactivity disorder (ADHD) is a clinically heterogeneous disorder whose diagnosis relies on a combination of questionnaires (self, parent or teacher-reported), clinical interviews and, in some cases, neuropsychiatric testing.

Accurate diagnosis of ADHD is important as, if left untreated, it is associated with negative socioeconomic outcomes such as poor scholastic performance, unemployment, criminality and increased risk of developing other mental health conditions such as substance abuse disorder. The results from a GlobalData high-prescriber survey performed in January 2024 suggest that diagnostic trends for ADHD across the seven major markets (7MM: France, Germany, Italy, Japan, Spain, the UK and the US) are being shaped...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Trends
FDA approves clinical trials for pig organ transplants
Transforming Clinical Trials with Alexander Saint-Amand
The New Product Development Landscape: Navigating the Challenges
Lindus Health completes $55m funding round
Bridging Clinical Research Gaps: How Site Augmentation Enhances Trial Success

Share This Article